Skip to content
sellWeak

Susan Eylward sold $3,950 of IMNN

General Counsel and Corp Sec at Imunon, Inc.. 2,525 shares at an average of $1.56, traded Aug 31, 2026, filed Sep 1, 2026.

Warning score
25
Value
$3,950
2,525 shares
Holdings after
2,896
-47% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $4k at market
    0
  • Share of holdings sold
    Sold 47% of holdings
    +10
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

IMNNOct 9, 2026 · close 1.08
Since filing Sep 1, 2026: -32.5%SPY +2.5% · excess -35.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001437749-26-029405, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 28, 2026AGrant or award
Common Stock
+2,525$1.60$4,0405,42142 d ago
Aug 31, 2026SOpen-market sale
Common Stock
-2,525$1.56$3,9502,89642 d ago

Related signals

Other insiders at Imunon, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
35Weak
IMNNsell
Imunon, Inc.
Susan Eylward
General Counsel and Corp Sec
$21k
11,800 shares
-80%
30Weak
IMNNbuy
Imunon, Inc.
Donald P Braun
director
$29k
25,000 shares
+4188%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.